Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes
Context: Chemerin is one of the adipokines that regulate fat metabolism. High-sensitivity C-reactive protein (hs-CRP) may be considered as a cardiovascular risk predictor. Measuring intima-media thickness of the CCA (C-IMT) is a well-evidenced tool for the detection of early stages of atherosclerosi...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-04-01
|
Series: | Therapeutic Advances in Endocrinology and Metabolism |
Online Access: | https://doi.org/10.1177/2042018816637312 |
id |
doaj-6c337647829e466d8e66060d87ef0954 |
---|---|
record_format |
Article |
spelling |
doaj-6c337647829e466d8e66060d87ef09542020-11-25T03:23:37ZengSAGE PublishingTherapeutic Advances in Endocrinology and Metabolism2042-01882042-01962016-04-01710.1177/2042018816637312Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetesNagwa A. LachineAbdel Aziz ElnekiedyMagdy Helmy MegallaaGihane I. KhalilMohamed A. SadakaKamel H. RohomaHeba S. KassabContext: Chemerin is one of the adipokines that regulate fat metabolism. High-sensitivity C-reactive protein (hs-CRP) may be considered as a cardiovascular risk predictor. Measuring intima-media thickness of the CCA (C-IMT) is a well-evidenced tool for the detection of early stages of atherosclerosis. We aimed here to study both serum chemerin and hs-CRP as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes, who are angiographically free of coronary artery disease (CAD). Subjects and methods: This cross-sectional study was conducted on 180 subjects divided into two groups: Group A included 90 type 2 diabetic patients without CAD and group B including 90 nondiabetic control subjects. All study subjects were having normal coronary angiography. Serum chemerin, homeostasis model assessment for insulin resistance (HOMA-IR), glycated haemoglobin (HbA1c), lipid profile, hs-CRP as well as C-IMT were assessed in all study subjects. Results: There was a statistically significant difference between the 2 groups regarding serum chemerin level, HOMA-IR, hs-CRP and C-IMT; being higher in the diabetic patients than in the control group ( p = 0.006, 0.024, 0.040 and <0.001, respectively). There was positive correlation between serum chemerin level and waist-to-hip ratio (WHR), HOMA-IR, hs-CRP and C-IMT. Carotid intima-media thickness was positively correlated with patients’ WHR, blood pressure, HbA1c, diabetes duration as well as hs-CRP, and negatively correlated with ankle-brachial index (ABI). Linear regression analysis showed that HbA1c, serum chemerin and hs-CRP were independently affecting C-IMT. Serum hs-CRP was positively correlated with HbA1c and HOMA-IR ( p = 0.006 and 0.032, respectively), and negatively correlated with HDL-cholesterol level ( p = 0.018). Conclusion: Both serum chemerin and hs-CRP could be considered as markers of subclinical atherosclerosis, and hence, may be utilized for the early detection of macrovascular disease, in Egyptian patients with type 2 diabetes.https://doi.org/10.1177/2042018816637312 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nagwa A. Lachine Abdel Aziz Elnekiedy Magdy Helmy Megallaa Gihane I. Khalil Mohamed A. Sadaka Kamel H. Rohoma Heba S. Kassab |
spellingShingle |
Nagwa A. Lachine Abdel Aziz Elnekiedy Magdy Helmy Megallaa Gihane I. Khalil Mohamed A. Sadaka Kamel H. Rohoma Heba S. Kassab Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes Therapeutic Advances in Endocrinology and Metabolism |
author_facet |
Nagwa A. Lachine Abdel Aziz Elnekiedy Magdy Helmy Megallaa Gihane I. Khalil Mohamed A. Sadaka Kamel H. Rohoma Heba S. Kassab |
author_sort |
Nagwa A. Lachine |
title |
Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes |
title_short |
Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes |
title_full |
Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes |
title_fullStr |
Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes |
title_full_unstemmed |
Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes |
title_sort |
serum chemerin and high-sensitivity c reactive protein as markers of subclinical atherosclerosis in egyptian patients with type 2 diabetes |
publisher |
SAGE Publishing |
series |
Therapeutic Advances in Endocrinology and Metabolism |
issn |
2042-0188 2042-0196 |
publishDate |
2016-04-01 |
description |
Context: Chemerin is one of the adipokines that regulate fat metabolism. High-sensitivity C-reactive protein (hs-CRP) may be considered as a cardiovascular risk predictor. Measuring intima-media thickness of the CCA (C-IMT) is a well-evidenced tool for the detection of early stages of atherosclerosis. We aimed here to study both serum chemerin and hs-CRP as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes, who are angiographically free of coronary artery disease (CAD). Subjects and methods: This cross-sectional study was conducted on 180 subjects divided into two groups: Group A included 90 type 2 diabetic patients without CAD and group B including 90 nondiabetic control subjects. All study subjects were having normal coronary angiography. Serum chemerin, homeostasis model assessment for insulin resistance (HOMA-IR), glycated haemoglobin (HbA1c), lipid profile, hs-CRP as well as C-IMT were assessed in all study subjects. Results: There was a statistically significant difference between the 2 groups regarding serum chemerin level, HOMA-IR, hs-CRP and C-IMT; being higher in the diabetic patients than in the control group ( p = 0.006, 0.024, 0.040 and <0.001, respectively). There was positive correlation between serum chemerin level and waist-to-hip ratio (WHR), HOMA-IR, hs-CRP and C-IMT. Carotid intima-media thickness was positively correlated with patients’ WHR, blood pressure, HbA1c, diabetes duration as well as hs-CRP, and negatively correlated with ankle-brachial index (ABI). Linear regression analysis showed that HbA1c, serum chemerin and hs-CRP were independently affecting C-IMT. Serum hs-CRP was positively correlated with HbA1c and HOMA-IR ( p = 0.006 and 0.032, respectively), and negatively correlated with HDL-cholesterol level ( p = 0.018). Conclusion: Both serum chemerin and hs-CRP could be considered as markers of subclinical atherosclerosis, and hence, may be utilized for the early detection of macrovascular disease, in Egyptian patients with type 2 diabetes. |
url |
https://doi.org/10.1177/2042018816637312 |
work_keys_str_mv |
AT nagwaalachine serumchemerinandhighsensitivitycreactiveproteinasmarkersofsubclinicalatherosclerosisinegyptianpatientswithtype2diabetes AT abdelazizelnekiedy serumchemerinandhighsensitivitycreactiveproteinasmarkersofsubclinicalatherosclerosisinegyptianpatientswithtype2diabetes AT magdyhelmymegallaa serumchemerinandhighsensitivitycreactiveproteinasmarkersofsubclinicalatherosclerosisinegyptianpatientswithtype2diabetes AT gihaneikhalil serumchemerinandhighsensitivitycreactiveproteinasmarkersofsubclinicalatherosclerosisinegyptianpatientswithtype2diabetes AT mohamedasadaka serumchemerinandhighsensitivitycreactiveproteinasmarkersofsubclinicalatherosclerosisinegyptianpatientswithtype2diabetes AT kamelhrohoma serumchemerinandhighsensitivitycreactiveproteinasmarkersofsubclinicalatherosclerosisinegyptianpatientswithtype2diabetes AT hebaskassab serumchemerinandhighsensitivitycreactiveproteinasmarkersofsubclinicalatherosclerosisinegyptianpatientswithtype2diabetes |
_version_ |
1724605371959476224 |